Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangcen Liu

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Cancer Cell|August 8, 2025
CHI3L3<sup>+</sup> immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastasesTao Shi, Wei Liu, Yuting Luo, et al.
Nature Communications|August 14, 2023
Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trialJia Wei, Xiaofeng Lu, Qin Liu, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Cancer Cell|August 8, 2025
CHI3L3<sup>+</sup> immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastasesTao Shi, Wei Liu, Yuting Luo, et al.
Nature Communications|August 14, 2023
Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trialJia Wei, Xiaofeng Lu, Qin Liu, et al.
Pageof 5